Titre:
  • Beyond trastuzumab: new treatment options for HER2-positive breast cancer.
Auteur:Saini, Kamal; Abdel Azim, Hatem Hamdy; Metzger-Filho, Otto; Loi, Sherene; Sotiriou, Christos; Azambuja, Evandro; Piccart-Gebhart, Martine
Informations sur la publication:Breast, 20 Suppl 3, page (S20-S27)
Statut de publication:Publié, 2011-10
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
HER2
Lapatinib
Neratinib
Pertuzumab
TDM1
Trastuzumab
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0960-9776
info:doi/10.1016/S0960-9776(11)70289-2
info:pii/S0960-9776(11)70289-2
info:scp/80054866591
info:pmid/22015288